Clinical Evaluation of an In-House Reverse Transcription-Competitive PCR for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma
暂无分享,去创建一个
[1] ntonio,et al. A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE , 2000 .
[2] J Kolberg,et al. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. , 1997, Nucleic acids research.
[3] Roger Detels,et al. Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.
[4] L. Cotte,et al. Development of a reverse transcriptase PCR-enzyme-linked immunosorbent assay for quantification of human immunodeficiency virus type 1 RNA in plasma: comparison with commercial quantitative assays , 1997, Journal of clinical microbiology.
[5] S. Kwok,et al. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity , 1997, Journal of clinical microbiology.
[6] M. Opravil,et al. Change in circulating levels of the chemokines macrophage inflammatory proteins 1α and 1β, RANTES, monocyte chemotactic protein‐1 and interleukin‐16 following treatment of severely immunodeficient HIV‐infected individuals with indinavir , 1997, AIDS.
[7] J. Laurence,et al. Quantitative RT-PCR for human Fas (CD95) expression. , 1997, BioTechniques.
[8] S. Yerly,et al. Detection of low HIV-1 RNA levels in plasma. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[9] T. Merigan,et al. Comparison of QIAamp HCV kit spin columns, silica beads, and phenol-chloroform for recovering human immunodeficiency virus type 1 RNA from plasma , 1997, Journal of clinical microbiology.
[10] T. Tanwandee,et al. Improved methods for quantification of human immunodeficiency virus type 1 RNA and hepatitis C virus RNA in blood using spin column technology and chemiluminescent assays of PCR products , 1997, Journal of medical virology.
[11] F. Brun-Vézinet,et al. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma , 1996, Journal of clinical microbiology.
[12] S. Hammer. Advances in antiretroviral therapy and viral load monitoring. , 1996, AIDS.
[13] M. Peeters,et al. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma , 1996, Journal of medical virology.
[14] M. Urdea,et al. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma , 1996, Journal of clinical microbiology.
[15] K. Harada,et al. Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects , 1996, Science.
[16] S. Hammer,et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. , 1996, The New England journal of medicine.
[17] Bradley Efron,et al. The Effect of High-Dose Saquinavir on Viral Load and CD4+ T-Cell Counts in HIV-Infected Patients , 1996, Annals of Internal Medicine.
[18] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[19] G. Zissis,et al. Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma , 1996, Journal of clinical microbiology.
[20] C. Hébrard,et al. Quantitation of human immunodeficiency virus type 1 DNA by two PCR procedures coupled with enzyme-linked oligosorbent assay , 1995, Journal of clinical microbiology.
[21] L. Kingsley,et al. Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay , 1995, Journal of clinical microbiology.
[22] R. Redfield,et al. Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort , 1995, Journal of virology.
[23] M. Clementi,et al. Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds , 1995, Journal of clinical microbiology.
[24] F. Jensen,et al. Development and validation of a polymerase chain reaction method for the precise quantitation of HIV‐1 DNA in blood cells from subjects undergoing a 1‐year immunotherapeutic treatment , 1993, AIDS.
[25] M. Clementi,et al. Quantitative PCR and RT-PCR in virology. , 1993, PCR methods and applications.
[26] J. Lifson,et al. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. , 1993, BioTechniques.
[27] D. Garling,et al. Rapid cycle DNA amplification: time and temperature optimization. , 1991, BioTechniques.